Study Condition(s): Psoriasis

A Study of Ixekizumab in Participants with Plaque Psoriasis

Study Alias: RHBU

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT02993471 {{ currentLocaleObject.registryAnchorText }}

Completed Completed

Study Purpose

The purpose of this study is to learn about how ixekizumab may affect the blood levels of a mixture of commonly used drugs.

Completed Study

The results of this study are not yet available.

Who Participated? Tool Tip Icon

Here you can find out a bit more about the requirements for volunteers who took part in this study


Male Female


18+ years

Time Commitment

Your participation could last up to 5 months with 6 overnight stays and approximately 13 outpatient visits.
  • Participant must have chronic moderate or severe plaque psoriasis for at least 6 months and are candidates for systemic therapy or phototherapy
  • Participant of childbearing potential must agree to use a reliable method of birth control
  • Participant must not have forms of psoriasis other than chronic plaque-type
  • Participant must not have participated in any other study with ixekizumab, secukinumab or brodalumab, or have been prescribed ixekizumab or secukinumab
  • Female participant must not be pregnant or nursing

Where This Study Took Place Tool Tip Icon

0 locations participated
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Closest Location
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Other Location(s)
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.